Please note that this summit has taken place. Catch up on some of the sessions you may have missed on the homepage.
Roche is the world’s largest biotech company and a global pioneer in diagnostics. Headquartered in Basel, Switzerland it has its home at the heart of Europe and today employs over 40,000 people, has significant R&D and manufacturing capabilities, and maintains a strong commitment to ensuring new medicines and integrated solutions are available and accessible to patients in all European countries, as and when they need them.
Europe has long stood strong as a leader in healthcare. It is the home of great scientists, physicians and academic institutions, a leader in the provision of universal healthcare, and a base for many of the innovative industries that have driven advances in patient care and outcomes. It has valued the health of its citizens, and understood the importance of science and innovation to improving it. In recent years, we have seen the global healthcare innovation landscape evolve and while the EU has made considerable progress to ensure that fundamental rights of EU citizens are protected, its efforts to leverage the benefits of digitalization and EU-wide data exchange for health and healthcare trail those of the US and China.
It doesn’t have to be like this – Europe has what it will take to address this challenge and has already announced an important new commitment to a European Health Union. With a bold and optimistic Pharmaceutical Strategy that uses transformative advances in science, technology, and the delivery of healthcare, Europe can boost patient outcomes, foster greater system sustainability and further confirm its position as a destination for healthcare innovation and investment.
We believe in the future of Europe as a centre for healthcare innovation and world class patient outcomes. We are committed to doing all we can to help make it a reality. Read more here.
Lilly’s purpose to make life better has never been more important. Lilly is bringing the full force of our scientific and medical expertise to attack COVID-19 around the world. We’re fighting the pandemic with everything we can by discovering potential medicines to treat and prevent COVID-19.
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Social media: Twitter
In Partnership with
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 36 national associations, 39 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.
with the support of
The European Patients’ Forum (EPF) is the leading voice of patient organisations across Europe. We are an umbrella organisation of patient organisations across Europe and across disease-areas. Our 75 members include disease-specific patient groups active at EU level and national coalitions of patients. www.eu-patient.eu